Clinical Trial Update: A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002) [Phase 1, Phase 2]

View source ↗

Summary

The document describes an ongoing Phase 1/2 clinical trial of MK-1045 (CN201) for precursor B-cell acute lymphoblastic leukemia that is currently recruiting in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Precursor B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• MK-1045 (CN201)

Snippet

Sponsor: MSD R&D (China) Co., Ltd. | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING